marketcaparena
Search

    QDEL

    QuidelOrtho Corp

    Company overview

    Market capitalization
    $742.67M
    Employees
    6,500
    Latest publication
    2026-09-29
    About QuidelOrtho Corp

    QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, to measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point of Care business unit provides instruments and tests to provide rapid results across a continuum of POC settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, Japan and Asia Pacific, and Latin America. The company was incorporated in 1979 and is headquartered in San Diego, California.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20252025-03-31 · USDQ3 20242024-09-30 · USDQ4 20232023-12-31 · USDQ3 20232023-09-30 · USDQ1 20232023-03-31 · USDQ4 20222022-12-31 · USDQ3 20222022-09-30 · USDQ2 20222022-06-30 · USD
    Total Revenue692,800,000USD727,100,000USD742,600,000USD744,000,000USD846,100,000USD866,500,000USD783,800,000USD613,400,000USD
    Cost Of Revenue349,500,000USD374,800,000USD361,300,000USD374,600,000USD397,500,000USD417,500,000USD376,300,000USD275,900,000USD
    Gross Profit343,300,000USD352,300,000USD381,300,000USD369,400,000USD448,600,000USD449,000,000USD407,500,000USD337,500,000USD
    Research Development53,200,000USD55,900,000USD59,300,000USD61,500,000USD62,300,000USD64,300,000USD65,600,000USD34,200,000USD
    Selling General Administrative187,000,000USD186,400,000USD172,500,000USD194,100,000USD7,333,000USD186,800,000USD204,200,000USD7,333,000USD
    Unclassified Operating Expenses70,500,000USD95,000,000USD94,300,000USD87,500,000USD279,367,000USD84,600,000USD80,900,000USD216,267,000USD
    Total Operating Expenses310,700,000USD337,300,000USD341,200,000USD343,100,000USD349,000,000USD362,500,000USD350,700,000USD257,800,000USD
    Operating Income32,600,000USD15,000,000USD40,100,000USD26,300,000USD99,600,000USD86,500,000USD56,800,000USD79,700,000USD
    Interest Income600,000USD400,000USD1,400,000USD1,300,000USD1,000,000USD300,000USD300,000USD400,000USD
    Interest Expense42,300,000USD49,500,000USD46,200,000USD29,200,000USD31,500,000USD32,600,000USD29,700,000USD10,300,000USD
    Net Interest Income-42,500,000USD-49,900,000USD-45,600,000USD-37,700,000USD-36,700,000USD-34,700,000USD-29,700,000USD-10,300,000USD
    Income Before Tax-8,800,000USD-28,800,000USD-9,200,000USD-15,500,000USD60,000,000USD41,100,000USD31,300,000USD42,900,000USD
    Income Tax Expense3,900,000USD-8,900,000USD-16,200,000USD-2,800,000USD11,200,000USD10,800,000USD12,100,000USD23,600,000USD
    Tax Provision3,900,000USD-8,900,000USD-16,200,000USD-2,800,000USD11,200,000USD10,800,000USD12,100,000USD23,600,000USD
    Net Income-12,700,000USD-19,900,000USD7,000,000USD-12,700,000USD48,800,000USD30,300,000USD19,200,000USD19,300,000USD
    Net Income From Continuing Ops-12,700,000USD-19,900,000USD7,000,000USD-12,700,000USD48,800,000USD30,300,000USD19,200,000USD19,300,000USD
    Ebit33,500,000USD20,700,000USD37,000,000USD31,100,000USD101,400,000USD78,300,000USD59,800,000USD51,600,000USD
    Ebitda140,600,000USD133,800,000USD152,400,000USD144,200,000USD215,600,000USD194,900,000USD164,000,000USD99,100,000USD
    Depreciation And Amortization107,100,000USD113,100,000USD115,400,000USD113,100,000USD114,200,000USD116,600,000USD104,200,000USD47,500,000USD
    Reconciled Depreciation107,100,000USD113,100,000USD115,400,000USD51,400,000USD50,800,000USD53,900,000USD50,500,000USD46,018,000USD
    Total Other Income Expense Net-41,400,000USD-43,800,000USD-49,300,000USD-41,800,000USD-39,600,000USD-45,400,000USD-25,500,000USD-36,800,000USD
    Selling And Marketing Expenses——15,100,000USD——26,800,000USD——
    Net Income Applicable To Common Shares———-12,700,000USD48,800,000USD30,300,000USD19,200,000USD19,300,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USDFY 20152015-12-31 · USD
    Total Revenue2,997,800,000USD3,266,000,000USD1,698,600,000USD1,661,668,000USD534,890,000USD522,285,000USD277,743,000USD196,129,000USD
    Cost Of Revenue1,500,700,000USD1,329,800,000USD420,300,000USD312,813,000USD214,085,000USD206,572,000USD121,601,000USD71,688,000USD
    Gross Profit1,497,100,000USD1,936,200,000USD1,278,300,000USD1,348,855,000USD320,805,000USD315,713,000USD156,142,000USD124,441,000USD
    Research Development246,800,000USD187,900,000USD95,700,000USD84,292,000USD52,553,000USD51,649,000USD33,644,000USD35,514,000USD
    Selling General Administrative748,100,000USD594,200,000USD225,900,000USD66,586,000USD52,755,000USD44,951,000USD29,192,000USD29,447,000USD
    Selling And Marketing Expenses15,100,000USD26,800,000USD13,700,000USD133,957,000USD111,114,000USD108,987,000USD67,248,000USD47,886,000USD
    Unclassified Operating Expenses348,000,000USD283,600,000USD37,000,000USD3,694,000USD11,667,000USD——8,856,000USD
    Total Operating Expenses1,358,000,000USD1,092,500,000USD372,300,000USD288,529,000USD228,089,000USD205,587,000USD130,084,000USD121,703,000USD
    Operating Income139,100,000USD843,700,000USD906,000,000USD1,060,326,000USD92,716,000USD95,929,000USD9,552,000USD2,738,000USD
    Interest Income5,500,000USD1,300,000USD300,000USD—14,790,000USD24,283,000USD17,588,000USD12,035,000USD
    Interest Expense178,900,000USD74,500,000USD700,000USD1,263,000USD14,790,000USD24,283,000USD17,588,000USD12,035,000USD
    Net Interest Income-176,700,000USD-75,700,000USD-5,706,000USD-9,623,000USD-14,790,000USD-24,283,000USD-17,588,000USD—
    Income Before Tax-29,100,000USD735,900,000USD900,300,000USD1,040,319,000USD77,178,000USD63,384,000USD-8,036,000USD-9,297,000USD
    Income Tax Expense-19,000,000USD187,200,000USD196,100,000USD230,032,000USD4,257,000USD-10,799,000USD129,000USD-3,218,000USD
    Tax Provision-19,000,000USD187,200,000USD196,133,000USD230,032,000USD4,257,000USD-10,799,000USD129,000USD-3,218,000USD
    Net Income-10,100,000USD548,700,000USD704,200,000USD810,287,000USD72,921,000USD74,183,000USD-8,165,000USD-6,079,000USD
    Net Income From Continuing Ops-10,100,000USD548,700,000USD704,226,000USD810,287,000USD72,921,000USD74,183,000USD-8,165,000USD-6,079,000USD
    Ebit149,800,000USD810,400,000USD900,600,000USD1,049,942,000USD91,968,000USD87,667,000USD9,552,000USD2,738,000USD
    Ebitda607,000,000USD1,094,000,000USD953,300,000USD1,099,031,000USD139,795,000USD133,933,000USD40,314,000USD11,594,000USD
    Depreciation And Amortization457,200,000USD283,600,000USD52,700,000USD49,089,000USD47,827,000USD46,266,000USD30,762,000USD8,856,000USD
    Reconciled Depreciation457,200,000USD132,500,000USD54,384,000USD49,089,000USD51,791,000USD46,266,000USD30,762,000USD—
    Total Other Income Expense Net-168,200,000USD-107,800,000USD-5,700,000USD-20,007,000USD-15,538,000USD-32,545,000USD-17,588,000USD-12,035,000USD
    Net Income Applicable To Common Shares—548,700,000USD704,226,000USD810,287,000USD72,921,000USD74,183,000USD-8,165,000USD-6,079,000USD
    Non Operating Income Net Other——-5,706,000USD-20,007,000USD-15,538,000USD-32,545,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Assets5,628,700,000USD5,769,300,000USD5,675,100,000USD6,379,100,000USD6,461,600,000USD6,423,600,000USD6,801,100,000USD6,689,200,000USD
    Intangible Assets2,520,200,000USD2,563,800,000USD2,608,000,000USD2,660,500,000USD2,697,900,000USD2,735,600,000USD2,795,900,000USD2,836,000,000USD
    Other Current Assets138,400,000USD250,500,000USD141,800,000USD154,200,000USD130,900,000USD135,600,000USD173,400,000USD159,400,000USD
    Total Liab3,777,300,000USD3,848,800,000USD3,638,700,000USD3,586,400,000USD3,464,400,000USD3,439,100,000USD3,614,400,000USD3,515,700,000USD
    Total Stockholder Equity1,851,400,000USD1,920,500,000USD2,036,400,000USD2,792,700,000USD2,997,200,000USD2,984,500,000USD3,186,700,000USD3,173,500,000USD
    Other Current Liab413,300,000USD429,800,000USD327,400,000USD292,500,000USD329,500,000USD341,000,000USD309,400,000USD243,900,000USD
    Common Stock100,000USD100,000USD100,000USD100,000USD100,000USD100,000USD100,000USD100,000USD
    Capital Stock100,000USD100,000USD100,000USD100,000USD100,000USD100,000USD100,000USD100,000USD
    Retained Earnings-1,087,800,000USD-996,000,000USD-865,300,000USD-132,300,000USD123,100,000USD135,800,000USD314,200,000USD334,100,000USD
    Cash140,400,000USD169,800,000USD98,100,000USD151,700,000USD127,100,000USD98,300,000USD143,700,000USD107,000,000USD
    Cash And Short Term Investments140,400,000USD202,200,000USD98,100,000USD151,700,000USD127,100,000USD98,300,000USD143,700,000USD107,000,000USD
    Total Current Assets1,377,000,000USD1,447,300,000USD1,366,700,000USD1,281,500,000USD1,258,200,000USD1,218,900,000USD1,412,600,000USD1,341,300,000USD
    Total Current Liabilities962,400,000USD966,100,000USD767,900,000USD1,142,100,000USD1,047,200,000USD998,800,000USD1,027,300,000USD932,400,000USD
    Current Deferred Revenue33,400,000USD37,800,000USD34,100,000USD40,200,000USD34,400,000USD33,500,000USD41,900,000USD40,100,000USD
    Net Debt2,734,300,000USD2,664,100,000USD2,745,700,000USD2,671,000,000USD2,567,100,000USD2,583,100,000USD2,612,000,000USD2,663,800,000USD
    Short Term Debt259,500,000USD207,600,000USD191,800,000USD564,200,000USD425,000,000USD372,900,000USD405,100,000USD385,900,000USD
    Short Long Term Debt228,200,000USD178,300,000USD162,500,000USD534,200,000USD393,800,000USD341,800,000USD373,800,000USD356,400,000USD
    Short Long Term Debt Total2,874,700,000USD2,833,900,000USD2,843,800,000USD2,822,700,000USD2,694,200,000USD2,681,400,000USD2,755,700,000USD2,770,800,000USD
    Long Term Debt2,459,800,000USD2,471,900,000USD2,496,500,000USD2,072,100,000USD2,105,900,000USD2,141,300,000USD2,176,600,000USD2,207,200,000USD
    Net Receivables486,700,000USD417,000,000USD513,000,000USD396,900,000USD437,000,000USD451,300,000USD518,500,000USD472,900,000USD
    Inventory611,500,000USD577,600,000USD613,800,000USD578,700,000USD563,200,000USD533,700,000USD577,000,000USD602,000,000USD
    Accounts Payable243,500,000USD279,400,000USD213,700,000USD218,800,000USD230,900,000USD246,000,000USD247,200,000USD237,400,000USD
    Property Plant Equipment Net1,497,300,000USD1,513,800,000USD1,480,300,000USD1,471,800,000USD1,564,400,000USD1,548,900,000USD1,539,200,000USD1,503,900,000USD
    Property Plant Equipment Gross2,497,300,000USD2,458,600,000USD2,359,200,000USD2,297,800,000USD2,349,100,000USD2,275,100,000USD1,539,200,000USD1,503,900,000USD
    Accumulated Other Comprehensive Income-4,099,999USD-15,400,000USD-19,700,000USD16,200,000USD-23,800,000USD-36,200,000USD-3,500,000USD-24,600,000USD
    Common Stock Shares Outstanding68,200,000shares67,800,000shares68,000,000shares67,700,000shares67,500,000shares67,200,000shares67,300,000shares67,099,999shares
    Non Current Assets Total4,251,700,000USD4,322,000,000USD4,308,400,000USD5,097,600,000USD5,203,400,000USD5,204,700,000USD5,388,500,000USD5,347,900,000USD
    Non Current Liabilities Total2,814,900,000USD2,882,700,000USD2,870,800,000USD2,444,300,000USD2,417,200,000USD2,440,300,000USD2,587,100,000USD2,583,300,000USD
    Non Current Liabilities Other112,400,000USD166,400,000USD138,700,000USD133,000,000USD69,800,000USD55,300,000USD119,300,000USD70,500,000USD
    Non Currrent Assets Other218,700,000USD244,400,000USD207,200,000USD240,000,000USD270,200,000USD249,000,000USD256,800,000USD250,300,000USD
    Net Working Capital414,600,000USD481,200,000USD598,800,000USD139,400,000USD211,000,000USD220,100,000USD385,300,000USD408,900,000USD
    Unclassified Current Liabilities-215,500,000USD-166,800,000USD-161,600,000USD-507,800,000USD-366,400,000USD-336,400,000USD-350,100,000USD-331,300,000USD
    Unclassified Non Current Liabilities242,700,000USD244,400,000USD235,600,000USD239,200,000USD241,500,000USD243,700,000USD291,200,000USD305,600,000USD
    Unclassified Equity2,943,099,999USD2,931,700,000USD2,921,200,000USD2,908,600,000USD2,897,700,000USD2,884,700,000USD2,875,800,000USD2,863,800,000USD
    Good Will—0USD0USD711,100,000USD670,900,000USD649,500,000USD770,600,000USD732,500,000USD
    Short Term Investments—32,400,000USD———0USD0USD48,400,000USD
    Long Term Investments—————0USD0USD0USD
    Unclassified Current Assets———————-48,400,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets5,769,300,000USD6,423,600,000USD8,563,100,000USD8,855,800,000USD2,430,400,000USD1,871,164,000USD910,867,000USD806,371,000USD
    Intangible Assets2,563,800,000USD2,735,600,000USD2,934,300,000USD3,123,800,000USD98,700,000USD122,431,000USD148,112,000USD175,029,000USD
    Other Current Assets250,500,000USD135,600,000USD77,000,000USD119,600,000USD19,200,000USD9,492,000USD9,013,000USD5,436,000USD
    Total Liab3,848,800,000USD3,439,100,000USD3,557,200,000USD3,921,200,000USD501,000,000USD538,461,000USD351,047,000USD380,787,000USD
    Total Stockholder Equity1,920,500,000USD2,984,500,000USD5,005,900,000USD4,934,600,000USD1,929,400,000USD1,332,703,000USD559,820,000USD425,584,000USD
    Other Current Liab429,800,000USD341,000,000USD306,700,000USD363,800,000USD132,700,000USD111,325,000USD78,567,000USD80,185,000USD
    Common Stock100,000USD100,000USD100,000USD—42,000USD42,000USD42,000USD39,000USD
    Capital Stock100,000USD100,000USD100,000USD0USD42,000USD42,000USD42,000USD39,000USD
    Retained Earnings-996,000,000USD135,800,000USD2,187,800,000USD2,197,900,000USD1,649,200,000USD944,971,000USD134,684,000USD61,763,000USD
    Good Will0USD649,500,000USD2,492,000,000USD2,476,800,000USD337,000,000USD337,032,000USD337,018,000USD337,021,000USD
    Cash169,800,000USD98,300,000USD118,900,000USD292,900,000USD802,800,000USD489,941,000USD52,775,000USD43,695,000USD
    Cash And Short Term Investments202,200,000USD98,300,000USD167,300,000USD345,000,000USD828,500,000USD489,941,000USD52,775,000USD43,695,000USD
    Total Current Assets1,447,300,000USD1,218,900,000USD1,310,500,000USD1,575,100,000USD1,440,300,000USD1,142,402,000USD222,227,000USD193,397,000USD
    Total Current Liabilities966,100,000USD998,800,000USD833,800,000USD1,007,000,000USD323,500,000USD336,961,000USD125,891,000USD159,735,000USD
    Current Deferred Revenue37,800,000USD33,500,000USD36,800,000USD76,400,000USD1,900,000USD3,733,000USD336,000USD63,557,000USD
    Net Debt2,664,100,000USD2,583,100,000USD2,495,200,000USD2,556,200,000USD-663,500,000USD-381,436,000USD59,525,000USD63,872,000USD
    Short Term Debt207,600,000USD372,900,000USD166,500,000USD231,900,000USD10,300,000USD7,799,000USD19,073,000USD54,379,000USD
    Short Long Term Debt178,300,000USD341,800,000USD139,800,000USD207,500,000USD300,000USD—12,661,000USD54,379,000USD
    Short Long Term Debt Total2,833,900,000USD2,681,400,000USD2,614,100,000USD2,849,100,000USD139,300,000USD108,505,000USD112,300,000USD107,567,000USD
    Long Term Debt2,471,900,000USD2,141,300,000USD2,274,800,000USD2,430,800,000USD400,000USD——53,188,000USD
    Short Term Investments32,400,000USD48,400,000USD48,400,000USD52,100,000USD25,700,000USD0USD——
    Net Receivables417,000,000USD451,300,000USD488,400,000USD586,400,000USD393,800,000USD529,171,000USD102,353,000USD76,887,000USD
    Inventory577,600,000USD533,700,000USD577,800,000USD524,100,000USD198,800,000USD113,798,000USD58,086,000USD67,379,000USD
    Accounts Payable279,400,000USD246,000,000USD294,800,000USD283,300,000USD101,500,000USD86,316,000USD26,701,000USD25,171,000USD
    Property Plant Equipment Net1,513,800,000USD1,548,900,000USD1,613,400,000USD1,520,000,000USD476,800,000USD211,025,000USD171,881,000USD73,901,000USD
    Property Plant Equipment Gross2,458,600,000USD2,275,100,000USD2,134,000,000USD1,520,000,000USD616,902,000USD211,025,000USD171,881,000USD73,901,000USD
    Accumulated Other Comprehensive Income-15,400,000USD-36,200,000USD-30,000,000USD-67,600,000USD400,000USD-431,000USD-463,000USD-139,000USD
    Common Stock Shares Outstanding67,800,000shares67,200,000shares66,800,000shares57,400,000shares42,874,000shares43,591,000shares43,111,000shares42,554,000shares
    Non Current Assets Total4,322,000,000USD5,204,700,000USD7,252,600,000USD7,280,700,000USD990,100,000USD728,762,000USD688,640,000USD612,974,000USD
    Non Current Liabilities Total2,882,700,000USD2,440,300,000USD2,723,400,000USD2,914,200,000USD177,500,000USD201,500,000USD225,156,000USD221,052,000USD
    Non Current Liabilities Other166,400,000USD55,300,000USD83,600,000USD83,800,000USD12,445,000USD26,843,000USD22,547,000USD24,706,000USD
    Non Currrent Assets Other244,400,000USD249,000,000USD179,600,000USD122,700,000USD19,600,000USD13,512,000USD7,127,000USD4,831,000USD
    Net Working Capital481,200,000USD220,100,000USD476,700,000USD568,100,000USD1,116,790,000USD805,441,000USD96,336,000USD33,662,000USD
    Unclassified Current Liabilities-166,800,000USD-336,400,000USD-110,800,000USD-155,900,000USD76,800,000USD127,788,000USD-11,447,000USD-117,936,000USD
    Unclassified Non Current Liabilities244,400,000USD243,700,000USD365,000,000USD101,200,000USD79,589,000USD4,012,000USD-34,327,000USD-167,864,000USD
    Unclassified Equity2,931,700,000USD2,884,700,000USD2,847,900,000USD2,804,300,000USD279,716,000USD388,079,000USD425,515,000USD363,882,000USD
    Long Term Investments—0USD7,400,000USD21,000,000USD37,852,000USD0USD——
    Unclassified Current Assets—-48,400,000USD——————
    Deferred Long Term Liab———3,500,000USD36,491,000USD73,951,000USD109,382,000USD143,158,000USD
    Other Liab———294,900,000USD48,575,000USD96,694,000USD127,554,000USD167,864,000USD
    Other Assets———395,800,000USD39,712,000USD158,818,000USD31,629,000USD27,023,000USD
    Net Tangible Assets———-666,000,000USD1,622,242,000USD973,946,000USD167,917,000USD-33,278,000USD
    Unclassified Non Current Assets———-379,400,000USD-19,564,000USD-114,056,000USD-7,127,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-91,800,000USD-130,699,999USD-733,000,000USD-255,400,000USD-12,700,000USD-178,400,000USD-19,900,000USD-147,700,000USD
    Depreciation112,900,000USD112,500,000USD112,100,000USD110,300,000USD107,100,000USD109,300,000USD113,100,000USD116,100,000USD
    Stock Based Compensation10,700,000USD10,800,000USD10,700,000USD12,800,000USD11,600,000USD9,600,000USD12,300,000USD11,200,000USD
    Other Non Cash Items4,900,000USD14,699,999USD700,500,000USD160,600,000USD5,100,000USD101,700,000USD-70,300,000USD51,900,000USD
    Change To Account Receivables54,000,000USD-28,800,000USD-113,400,000USD22,500,000USD2,200,000USD-2,200,000USD-16,600,000USD-2,200,000USD
    Change To Inventory-72,600,000USD-6,600,000USD-39,100,000USD-49,500,000USD-53,100,000USD-23,200,000USD-15,700,000USD-57,500,000USD
    Change In Working Capital-67,900,000USD129,100,000USD-134,800,000USD-74,700,000USD-45,400,000USD48,200,000USD9,100,000USD-129,700,000USD
    Total Cash From Operating Activities-33,000,000USD131,900,000USD-45,500,000USD-46,800,000USD65,600,000USD63,700,000USD117,900,000USD-97,900,000USD
    Capital Expenditures6,200,000USD-45,300,000USD-49,200,000USD6,500,000USD10,100,000USD-47,200,000USD-46,500,000USD-35,300,000USD
    Free Cash Flow-26,800,000USD86,600,000USD-94,700,000USD-40,300,000USD75,700,000USD16,500,000USD71,400,000USD-133,200,000USD
    Total Cashflows From Investing Activities-34,000,000USD-49,600,000USD-53,900,000USD-33,000,000USD-56,200,000USD-37,900,000USD-56,500,000USD-35,300,000USD
    Net Borrowings36,900,000USD-10,800,000USD44,000,000USD105,900,000USD16,000,000USD-68,000,000USD-26,300,000USD—
    Total Cash From Financing Activities37,600,000USD-11,100,000USD46,000,000USD103,300,000USD17,600,000USD-68,900,000USD-26,300,000USD162,500,000USD
    Issuance Of Capital Stock1,800,000USD100,000USD2,900,000USD100,000USD3,000,000USD0USD400,000USD4,100,000USD
    Change In Cash-29,400,000USD71,700,000USD-53,600,000USD24,500,000USD28,700,000USD-45,500,000USD36,500,000USD28,500,000USD
    Begin Period Cash Flow169,800,000USD98,100,000USD151,700,000USD127,200,000USD98,500,000USD144,000,000USD107,000,000USD78,500,000USD
    End Period Cash Flow140,400,000USD169,800,000USD98,100,000USD151,700,000USD127,200,000USD98,500,000USD144,000,000USD107,000,000USD
    Other Cashflows From Investing Activities-34,000,000USD-4,300,000USD-4,700,000USD-39,500,000USD-66,300,000USD9,300,000USD-10,000,000USD78,800,000USD
    Other Cashflows From Financing Activities-1,100,000USD-400,000USD-900,000USD-2,700,000USD-1,400,000USD-32,000,000USD-400,000USD-2,500,000USD
    Unclassified Operating Cash Flow-1,800,000USD-4,500,000USD———-26,700,000USD73,600,000USD—
    Unclassified Investing Cash Flow-6,200,000USD—53,900,000USD33,000,000USD56,200,000USD37,900,000USD56,500,000USD-43,500,000USD
    Investments—0USD-53,900,000USD-33,000,000USD-56,200,000USD-37,900,000USD-56,500,000USD-35,300,000USD
    Sale Purchase Of Stock—————-900,000USD8,300,000USD-7,200,000USD
    Unclassified Financing Cash Flow—————32,000,000USD-7,900,000USD185,200,000USD
    Dividends Paid———————-13,000,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-1,131,800,000USD-2,052,000,000USD-10,100,000USD548,700,000USD704,226,000USD810,287,000USD72,921,000USD74,183,000USD
    Depreciation442,000,000USD453,400,000USD457,200,000USD283,600,000USD54,384,000USD49,089,000USD47,827,000USD46,266,000USD
    Stock Based Compensation45,900,000USD42,100,000USD51,600,000USD48,400,000USD25,400,000USD21,019,000USD13,252,000USD11,709,000USD
    Other Non Cash Items868,600,000USD1,897,500,000USD-12,000,000USD101,800,000USD-34,000USD20,647,000USD17,466,000USD26,978,000USD
    Change To Account Receivables-117,500,000USD5,400,000USD160,000,000USD150,200,000USD118,852,000USD-402,094,000USD-36,059,000USD8,236,000USD
    Change To Inventory-148,300,000USD-134,100,000USD-211,600,000USD-116,900,000USD-85,039,000USD-54,903,000USD9,143,000USD-3,974,000USD
    Change In Working Capital-125,800,000USD-158,700,000USD-194,900,000USD-53,200,000USD-2,780,000USD-251,068,000USD-15,239,000USD-2,333,000USD
    Total Cash From Operating Activities105,200,000USD83,000,000USD280,200,000USD885,300,000USD805,869,000USD629,763,000USD134,485,000USD136,345,000USD
    Capital Expenditures-188,200,000USD-195,100,000USD-209,300,000USD-140,900,000USD-292,724,000USD-64,927,000USD-27,229,000USD-31,689,000USD
    Free Cash Flow-83,000,000USD-112,100,000USD70,900,000USD744,400,000USD513,145,000USD564,836,000USD107,256,000USD104,656,000USD
    Investments0USD-149,900,000USD-187,600,000USD-1,644,200,000USD-63,687,000USD-63,322,000USD-27,229,000USD114,955,000USD
    Total Cashflows From Investing Activities-192,700,000USD-149,900,000USD-187,600,000USD-1,644,200,000USD-319,530,000USD-63,322,000USD-27,229,000USD114,955,000USD
    Net Borrowings155,100,000USD53,400,000USD-226,400,000USD346,200,000USD-260,000USD-511,000USD-54,292,000USD-204,458,000USD
    Total Cash From Financing Activities155,800,000USD48,800,000USD-265,800,000USD252,000,000USD-173,177,000USD-130,277,000USD-98,282,000USD-244,058,000USD
    Sale Purchase Of Stock0USD-9,600,000USD-7,200,000USD-74,300,000USD-103,438,000USD-43,691,000USD-10,728,000USD-4,344,000USD
    Issuance Of Capital Stock6,100,000USD5,000,000USD11,600,000USD26,400,000USD7,550,000USD9,613,000USD14,782,000USD17,047,000USD
    Change In Cash71,300,000USD-21,000,000USD-174,400,000USD-508,900,000USD312,810,000USD437,166,000USD9,080,000USD7,609,000USD
    Begin Period Cash Flow98,500,000USD119,500,000USD293,900,000USD802,800,000USD489,941,000USD52,775,000USD43,695,000USD36,086,000USD
    End Period Cash Flow169,800,000USD98,500,000USD119,500,000USD293,900,000USD802,751,000USD489,941,000USD52,775,000USD43,695,000USD
    Other Cashflows From Investing Activities-11,000,000USD-10,700,000USD3,500,000USD18,400,000USD36,881,000USD1,605,000USD1,605,000USD146,644,000USD
    Other Cashflows From Financing Activities-5,400,000USD-9,600,000USD-43,800,000USD-46,300,000USD-76,977,000USD-52,242,000USD-59,505,000USD-54,818,000USD
    Unclassified Operating Cash Flow6,300,000USD-99,300,000USD-11,600,000USD-44,000,000USD24,673,000USD-20,211,000USD-1,742,000USD-20,458,000USD
    Unclassified Investing Cash Flow6,500,000USD205,800,000USD205,800,000USD122,500,000USD—63,322,000USD25,624,000USD-114,955,000USD
    Unclassified Financing Cash Flow6,100,000USD14,600,000USD11,600,000USD26,400,000USD7,498,000USD-33,833,000USD26,243,000USD19,562,000USD
    Change To Liabilities———23,500,000USD-23,337,000USD220,193,000USD7,363,000USD6,086,000USD
    Cash And Cash Equivalents Changes————313,162,000USD436,164,000USD9,080,000USD7,609,000USD
    Exchange Rate Changes——————106,000USD367,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2026Quarterly · 2026-03-31GeographyEMEA92,500,000USD0001906324-26-000024
    Q1 2026Quarterly · 2026-03-31GeographyLatin America64,900,000USD0001906324-26-000024
    Q1 2026Quarterly · 2026-03-31GeographyNorth America328,900,000USD0001906324-26-000024
    Q1 2026Quarterly · 2026-03-31GeographyOther133,500,000USD0001906324-26-000024
    Q1 2026Quarterly · 2026-03-31SegmentChina63,500,000USD0001906324-26-000024
    Q1 2026Quarterly · 2026-03-31SegmentJPAC70,000,000USD0001906324-26-000024
    Q1 2026Quarterly · 2026-03-31SegmentOther4,800,000USD0001906324-26-000024
    Q1 2025Quarterly · 2025-03-31GeographyEMEA88,900,000USD0001906324-26-000024
    Q1 2025Quarterly · 2025-03-31GeographyLatin America54,100,000USD0001906324-26-000024
    Q1 2025Quarterly · 2025-03-31GeographyNorth America406,700,000USD0001906324-26-000024
    Q1 2025Quarterly · 2025-03-31GeographyOther143,100,000USD0001906324-26-000024
    Q1 2025Quarterly · 2025-03-31SegmentChina75,000,000USD0001906324-26-000024
    Q1 2025Quarterly · 2025-03-31SegmentJPAC68,100,000USD0001906324-26-000024
    Q1 2025Quarterly · 2025-03-31SegmentOther27,800,000USD0001906324-26-000024
    FY 2024Yearly · 2024-12-31SegmentChina325,000,000USD0001906324-26-000008
    FY 2024Yearly · 2024-12-31SegmentJPAC279,400,000USD0001906324-26-000008
    FY 2024Yearly · 2024-12-31SegmentOther90,200,000USD0001906324-26-000008
    Q3 2024Quarterly · 2024-09-30SegmentChina80,400,000USD0001906324-24-000049
    Q3 2024Quarterly · 2024-09-30SegmentOther126,500,000USD0001906324-24-000049
    FY 2023Yearly · 2023-12-31GeographyDomestic Country1,829,400,000USD0001906324-24-000011
    FY 2023Yearly · 2023-12-31GeographyForeign Country1,168,400,000USD0001906324-24-000011
    Q3 2023Quarterly · 2023-09-30SegmentChina81,100,000USD0001906324-24-000049
    Q3 2023Quarterly · 2023-09-30SegmentOther152,000,000USD0001906324-24-000049
    Q1 2023Quarterly · 2023-03-31GeographyChina70,600,000USD0001906324-23-000033
    Q1 2023Quarterly · 2023-03-31GeographyEMEA81,300,000USD0001906324-23-000033
    Q1 2023Quarterly · 2023-03-31GeographyNorth America582,800,000USD0001906324-23-000033
    Q1 2023Quarterly · 2023-03-31GeographyOther111,400,000USD0001906324-23-000033
    FY 2022Yearly · 2022-12-31GeographyDomestic Country2,451,700,000USD0001906324-24-000011
    FY 2022Yearly · 2022-12-31GeographyForeign Country814,300,000USD0001906324-24-000011
    Q3 2022Quarterly · 2022-09-30GeographyEMEA73,700,000USD0001906324-23-000058
    Q3 2022Quarterly · 2022-09-30GeographyNorth America517,600,000USD0001906324-23-000058
    Q3 2022Quarterly · 2022-09-30GeographyOther192,500,000USD0001906324-23-000058
    Q2 2022Quarterly · 2022-06-30GeographyEMEA42,100,000USD0001906324-23-000046
    Q2 2022Quarterly · 2022-06-30GeographyNorth America438,200,000USD0001906324-23-000046
    Q2 2022Quarterly · 2022-06-30GeographyOther133,100,000USD0001906324-23-000046
    Q2 2022Quarterly · 2022-06-30SegmentChina73,600,000USD0001906324-23-000046
    Q2 2022Quarterly · 2022-06-30SegmentOther83,800,000USD0001906324-23-000046
    Q1 2022Quarterly · 2022-03-31GeographyChina8,700,000USD0001906324-23-000033
    Q1 2022Quarterly · 2022-03-31GeographyEMEA15,200,000USD0001906324-23-000033
    Q1 2022Quarterly · 2022-03-31GeographyNorth America961,500,000USD0001906324-23-000033
    Q1 2022Quarterly · 2022-03-31GeographyOther16,900,000USD0001906324-23-000033
    Q1 2022Quarterly · 2022-03-31ProductCardiac Immunoassay50,153,000USD0000353569-22-000043
    Q1 2022Quarterly · 2022-03-31ProductMolecular Diagnostic Solutions45,989,000USD0000353569-22-000043
    Q1 2022Quarterly · 2022-03-31ProductRapid Immunoassay892,810,000USD0000353569-22-000043
    Q1 2022Quarterly · 2022-03-31ProductSpecialized Diagnostic Solutions13,307,000USD0000353569-22-000043
    FY 2021Yearly · 2021-12-31SegmentCardiac Immunoassay255,788,000USD0000353569-22-000026
    FY 2021Yearly · 2021-12-31SegmentImmunoassays1,197,459,000USD0000353569-22-000026
    FY 2021Yearly · 2021-12-31SegmentMolecular Diagnostic Solutions200,487,000USD0000353569-22-000026
    FY 2021Yearly · 2021-12-31SegmentSpecialized Diagnostic Solutions44,817,000USD0000353569-22-000026
    FY 2021Yearly · 2021-12-31GeographyDomestic Country1,415,500,000USD0001906324-24-000011
    FY 2021Yearly · 2021-12-31GeographyForeign Country283,100,000USD0001906324-24-000011
    Q3 2021Quarterly · 2021-09-30GeographyEMEA14,800,000USD0001906324-22-000033
    Q3 2021Quarterly · 2021-09-30GeographyNorth America466,800,000USD0001906324-22-000033
    Q3 2021Quarterly · 2021-09-30GeographyOther28,200,000USD0001906324-22-000033
    Q3 2021Quarterly · 2021-09-30ProductCardiac Immunoassay64,790,000USD0000353569-21-000091
    Q3 2021Quarterly · 2021-09-30ProductMolecular Diagnostic Solutions54,834,000USD0000353569-21-000091
    Q3 2021Quarterly · 2021-09-30ProductRapid Immunoassay378,721,000USD0000353569-21-000091
    Q3 2021Quarterly · 2021-09-30ProductSpecialized Diagnostic Solutions11,391,000USD0000353569-21-000091
    Q2 2021Quarterly · 2021-06-30GeographyEMEA17,900,000USD0001906324-22-000011
    Q2 2021Quarterly · 2021-06-30GeographyNorth America122,000,000USD0001906324-22-000011
    Q2 2021Quarterly · 2021-06-30GeographyOther36,700,000USD0001906324-22-000011
    Q2 2021Quarterly · 2021-06-30ProductCardiac Immunoassay71,666,000USD0000353569-21-000079
    Q2 2021Quarterly · 2021-06-30ProductMolecular Diagnostic Solutions34,456,000USD0000353569-21-000079
    Q2 2021Quarterly · 2021-06-30ProductRapid Immunoassay60,070,000USD0000353569-21-000079
    Q2 2021Quarterly · 2021-06-30ProductSpecialized Diagnostic Solutions10,418,000USD0000353569-21-000079
    Q1 2021Quarterly · 2021-03-31ProductCardiac Immunoassay66,552,000USD0000353569-22-000043
    Q1 2021Quarterly · 2021-03-31ProductMolecular Diagnostic Solutions60,263,000USD0000353569-22-000043
    Q1 2021Quarterly · 2021-03-31ProductRapid Immunoassay237,670,000USD0000353569-22-000043
    Q1 2021Quarterly · 2021-03-31ProductSpecialized Diagnostic Solutions10,853,000USD0000353569-22-000043
    FY 2020Yearly · 2020-12-31SegmentCardiac Immunoassay242,933,000USD0000353569-22-000026
    FY 2020Yearly · 2020-12-31SegmentImmunoassays1,144,831,000USD0000353569-22-000026
    FY 2020Yearly · 2020-12-31SegmentMolecular Diagnostic Solutions222,964,000USD0000353569-22-000026
    FY 2020Yearly · 2020-12-31SegmentSpecialized Diagnostic Solutions50,940,000USD0000353569-22-000026
    FY 2020Yearly · 2020-12-31GeographyDomestic Country1,452,400,000USD0001906324-23-000014
    FY 2020Yearly · 2020-12-31GeographyForeign Country209,300,000USD0001906324-23-000014
    Q3 2020Quarterly · 2020-09-30ProductCardiac Immunoassay64,810,000USD0000353569-21-000091
    Q3 2020Quarterly · 2020-09-30ProductMolecular Diagnostic Solutions62,993,000USD0000353569-21-000091
    Q3 2020Quarterly · 2020-09-30ProductRapid Immunoassay337,042,000USD0000353569-21-000091
    Q3 2020Quarterly · 2020-09-30ProductSpecialized Diagnostic Solutions11,213,000USD0000353569-21-000091
    Q2 2020Quarterly · 2020-06-30ProductCardiac Immunoassay54,191,000USD0000353569-21-000079
    Q2 2020Quarterly · 2020-06-30ProductMolecular Diagnostic Solutions55,177,000USD0000353569-21-000079
    Q2 2020Quarterly · 2020-06-30ProductRapid Immunoassay80,606,000USD0000353569-21-000079
    Q2 2020Quarterly · 2020-06-30ProductSpecialized Diagnostic Solutions11,780,000USD0000353569-21-000079
    Q1 2020Quarterly · 2020-03-31ProductCardiac Immunoassay53,901,000USD0000353569-21-000054
    Q1 2020Quarterly · 2020-03-31ProductMolecular Diagnostic Solutions8,363,000USD0000353569-21-000054
    Q1 2020Quarterly · 2020-03-31ProductRapid Immunoassay95,930,000USD0000353569-21-000054
    Q1 2020Quarterly · 2020-03-31ProductSpecialized Diagnostic Solutions16,459,000USD0000353569-21-000054
    FY 2019Yearly · 2019-12-31SegmentCardiac Immunoassay266,505,000USD0000353569-22-000026
    FY 2019Yearly · 2019-12-31SegmentImmunoassays191,736,000USD0000353569-22-000026
    FY 2019Yearly · 2019-12-31SegmentMolecular Diagnostic Solutions21,716,000USD0000353569-22-000026
    FY 2019Yearly · 2019-12-31SegmentSpecialized Diagnostic Solutions54,933,000USD0000353569-22-000026
    FY 2019Yearly · 2019-12-31GeographyDomestic Country358,381,000USD0000353569-22-000026
    FY 2019Yearly · 2019-12-31GeographyForeign Country176,509,000USD0000353569-22-000026
    Q3 2019Quarterly · 2019-09-30ProductCardiac Immunoassay66,820,000USD0000353569-20-000072
    Q3 2019Quarterly · 2019-09-30ProductMolecular Diagnostic Solutions4,683,000USD0000353569-20-000072
    Q3 2019Quarterly · 2019-09-30ProductRapid Immunoassay42,534,000USD0000353569-20-000072
    Q3 2019Quarterly · 2019-09-30ProductSpecialized Diagnostic Solutions12,455,000USD0000353569-20-000072
    FY 2018Yearly · 2018-12-31SegmentCardiac Immunoassay266,524,000USD0000353569-21-000028
    FY 2018Yearly · 2018-12-31SegmentImmunoassays183,160,000USD0000353569-21-000028
    FY 2018Yearly · 2018-12-31SegmentMolecular Diagnostic Solutions19,358,000USD0000353569-21-000028

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.